Evidence map›Paper›PMID 30200627›Full record

ArticleNutrients2018

Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer's Disease.

Desanka Milanovic, Snjezana Petrovic, Marjana Brkic, Vladimir Avramovic, Milka Perovic, Sanja Ivkovic, Marija Glibetic, Selma Kanazir

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Role of Mfsd2a in Nervous System Diseases.Frontiers in neuroscience · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Desanka MilanovicDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. desan@ibiss.bg.ac.rs.
Snjezana PetrovicCenter of Excellence in Nutrition and Metabolism Research, CENM, Tadeusa Koscuska 1, 11000 Belgrade, Serbia. snjezana570.imr12@gmail.com.ORCID 0000-0002-1387-9777
Marjana BrkicDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. marjana.brkic@ibiss.bg.ac.rs.
Vladimir AvramovicDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. vladimir.avramovic@ibiss.bg.ac.rs.
Milka PerovicDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. milkap@ibiss.bg.ac.rs.ORCID 0000-0003-0941-6988
Sanja IvkovicDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. sanja.ivkovic@ibiss.bg.ac.rs.
Marija GlibeticCenter of Excellence in Nutrition and Metabolism Research, CENM, Tadeusa Koscuska 1, 11000 Belgrade, Serbia. mglibetic@gmail.com.
Selma KanazirDepartment of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia. selkan@ibiss.bg.ac.rs.ORCID 0000-0002-7229-5296
University of Belgrade · RSCentre of Research Excellence in Nutrition and Metabolism · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term fish oil (FO) supplementation is able to improve Alzheimer's disease (AD) pathology. We aimed to determine the impact of short-term fish oil (FO) intake on phospholipids composition and plaque pathology in 5xFAD mice, a widely used animal model of AD. A 3-week-long FO supplementation administered at 3 months of age decreased the number of dense core plaques in the 5xFAD cortex and changed phospholipids in the livers and brains of wild-type (Wt) and 5xFAD mice. Livers of both genotypes responded by increase of

Indexed as

Dietary SupplementsPlaque, AmyloidAlzheimer DiseaseAnimalsBrainDisease Models, AnimalFemaleFish OilsGenetic Predisposition to DiseaseLiverMaleMembrane Transport ProteinsMice, TransgenicPhenotypePhospholipidsSymportersFish OilsMembrane Transport ProteinsMfsd2a protein, mousePhospholipidsSymportersAlzheimer’s diseaseamyloid-βdocosahexaenoic acidMfsd2an-3 polyunsaturated fatty acidsn-6 fatty acids

Identifiers

PMID30200627
PMCPMC6165196
OpenAlexW2890253588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.